LD-2 disclosure · 4th Quarter - Termination Amendment
LIFE TECHNOLOGIES CORPORATION
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- GLOBAL BIOTECHNOLOGY TOOLS COOMPANY
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
4 issuesCopyright/Patent/Trademark
H.R. 3309: The Innovation Act; Provisions regarding patent litigation reform.
Lobbyistsms JANET LYNCH LAMBERT
Covered position (ms JANET LYNCH LAMBERT): N/A
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
Subregulatory: Molecular Pathology Fee Schedules; Provisions regarding Medicare rate settings for certain diagnostics. S. 1871: The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; Provisions regarding diagnostic amendments.
LobbyistsAMY MUHLBERG
Covered position (AMY MUHLBERG): N/A
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Medical/Disease Research/Clinical Labs
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.